



Evaluation of the probiotic and postbiotic potential of lactic acid bacteria 
from artisanal dairy products against pathogens  
 
Nazar Hussain1,2,3, Muhammad Tariq1,2, Per Erik Joakim Saris3, Arsalan Zaidi1,2 
 
1 National Probiotics Lab-HBD, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, 
Pakistan 
2 Pakistan Institute of Engineering and Applied Sciences, Nilore, Islamabad, Pakistan 
3 Department of Microbiology, University of Helsinki, Helsinki, Finland  
 
Abstract 
Introduction: Probiotic and postbiotic potential of thirty-two strains of lactic acid bacteria (LAB), obtained earlier from artisanal dairy sources 
in Pakistan, have been investigated against major multi-drug resistant (MDR) and food borne pathogenic bacteria. 
Methodology: LAB strains were identified by 16S rRNA gene sequencing and their antibacterial activity was assessed by the microdilution 
method. Four LAB isolates, Weissella confusa PL6, Enterococcus faecium PL7, and Lactobacillus delbrueckii PL11 and PL13 were shortlisted. 
Their ability to degrade lactose and safety for human consumption in terms of hemolysis and antibiotic susceptibility were assessed in vitro. 
The antibacterial components in the cell-free supernatants (CFSs) of isolate cultures were characterized biochemically by HPLC. 
Results: Acid neutralization but not protease treatment abolished the antibacterial activity of CFSs. Lactic, acetic and propionic acids were the 
main acids in the CFSs, and acid production peaked in the stationary phase of growth. The antibacterial activity of the LAB cultures resulted 
from secretion of organic acids that lowered the pH. The strains exhibited variable ability to degrade lactose and were non-hemolytic and 
susceptible to the most common antibiotics. 
Conclusions: These LAB strains are probiotic candidates for further investigation of their postbiotic role in naturally preserving processed 
foods and for attenuation of lactose intolerance. 
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Introduction 
The recurrence of bacterial infections because of the 
development of antibiotic resistance has become a 
paramount public health concern [1]. For many years, 
conventional antibiotics have been at the forefront of 
infection treatments [2], but due to the rise in bacterial 
multidrug resistance (MDR), the standard antibiotic 
regimens have lost effectiveness [3,4]. These MDR 
pathogens are not only a cause of public concern in 
hospitals but lately, foods of animal origin have also 
become a conduit for their spread in communities [5]. 
In many MDR cases, only a few antibiotics remain 
effective and it is only a matter of time before these 
drugs also lose their potency [4]. Salmonella spp. is a 
globally recognized foodborne pathogen. The MDR 
phenotype has shown a high prevalence in Pakistan [6], 
but the incidence of extensively drug-resistant (XDR) 
Salmonella spp. has also been reported [7]. 
Pseudomonas aeruginosa is another well-known 
pathogen implicated in 10% of all hospital-acquired 
infections the world over [8]. It was found to have 
MDR, XDR and even pan drug-resistant (PDR) 
phenotypes in Pakistan [9]. Staphylococcus aureus is 
also regarded as a significant human pathogen 
frequently occurring in food of animal origin [10] and 
increasingly reported to be of the MDR variety [11]. 
Usually a harmless member of the gut microbiome, 
Escherichia coli can also be an opportunistic pathogen 
causing recalcitrant urinary tract and bloodstream 
infections [12,13]. Lately, its strains too have been 
appearing in Pakistan with purported MDR 
characteristics [14]. After weaning, around 75% of the 
world’s population experiences a decline in lactase 
activity in the small intestine due to genetic factors [15]. 
Low level of lactase activity cause maldigestion of 
lactose and malabsorption in the small intestine [16]. 
Lactose maldigestion affects around 60% of Pakistan’s 
adult population [17]. Treatment of lactose intolerance 
is currently restricted to medications and supplements 
that either have a preventive or a symptom management 
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function [18]. Lactose-free products and non-dairy 
fermented foods are also available in markets [19], but 
lactose is important especially for children, as it is the 
only disaccharide that does not appear to accentuate the 
risk of dental caries [20]. 
To replace the steadily decreasing arsenal of 
effective antimicrobials and to alleviate lactose 
intolerance, several alternatives are being tested. 
Foremost among these strategies are metabolites 
produced by LABs either during their lifetime or after 
death, the latter known as postbiotics [21]. Because of 
their broad-acting antibacterial activity and unique 
mechanisms of action, these products hold much 
promise against human pathogens [22] and are being 
increasingly applied in clinical and industrial settings. 
Several different substances, such as organic acids 
(lactic, phenyl lactic and acetic acid), ammonia, free 
fatty acids, acetaldehyde, diacetyl, hydrogen peroxide, 
and even peptides have been identified as the 
underlying antimicrobial agents [23]. Candidate 
bacterial strains or their postbiotics could be screened 
as options for treating MDR infections or eliminating 
pathogens from the food chain. A collection of LAB 
gathered from dairy foods were identified and 
characterized for their antibacterial activity against 




LAB strains and culture conditions 
The thirty-two LAB isolates were obtained from the 
culture collection of the National Probiotic Lab, 
National Institute for Biotechnology and Genetic 
Engineering (NIBGE) Faisalabad, Pakistan (Table 1) 
and were regrown on de Man, Rogosa and Sharpe 
(MRS, Merck, Darmstadt, Germany) agar plates with 
incubation for 24 hours at 37˚C. The identities of the 
partial 16S rRNA gene sequences of the isolates 
previously submitted to GenBank were confirmed by a 
BLAST database search on NCBI. Sequences with ≥ 
Table 1. Detail of LAB strains used in present study. 
Strain code* Source Accession number Strain identification 
PL1 Raw cow milk KT626385 Lactobacillus plantarum 
PL3 Homemade yogurt KT626387 Lactobacillus rhamnosus1 
PL4 Homemade yogurt KT626388 Lactobacillus delbrueckii 
PL5 Raw cow milk KT626389 Lactobacillus Paracasei1 
PL6 Raw cow milk KT626390 Weissella confusa 
PL7 Raw cow milk KT626391 Enterococcus faecium 
PL8 Raw cow milk KT626392 Enterococcus faecium 
PL9 Homemade yogurt KT626392 Lactobacillus delbrueckii 
PL10 Raw cow milk KT626394 Weissella paramesenteroides 
PL11 Homemade yogurt KT626395 Lactobacillus delbrueckii 
PL12 Homemade yogurt KT626396 Lactobacillus delbrueckii 
PL13 Homemade yogurt KT626397 Lactobacillus delbrueckii 
PL14 Raw cow milk KT626398 Lactobacillus sakei subsp. sakei 
PL15 Raw cow milk KT626399 Lactobacillus sakei subsp. sakei 
PL16 Local cheese KT626400 Streptococcus lutetiensis 
PL17 Local cheese KT626401 Enterococcus faecium 
PL18 Local cheese KT626402 Lactobacillus paracasei1 
PL19 Local cheese KT626403 Leuconostoc lactis 
PL20 Local cheese KT626404 Lactobacillus fermentum1 
PL21 Raw goat milk KT626405 Weissella confusa 
PL22 Raw sheep milk KT626406 Lactobacillus fermentum 
PL23 Raw buffalo milk KT626407 Streptococcus lutetiensis 
PL24 Raw cow milk KT626408 Lactobacillus fermentum1 
PL25 Raw goat milk KT626409 Lactobacillus fermentum1 
PL26 Raw goat milk KT626410 Lactobacillus fermentum1 
PL27 Raw goat milk KT626411 Lactobacillus fermentum1 
PL28 Raw sheep milk KT626412 Lactobacillus fermentum1 
PL29 Raw cow milk KT626413 Lactobacillus fermentum1 
PL30 Raw sheep milk KT626414 Lactobacillus fermentum1 
PL31 Raw cow milk KT626415 Lactobacillus fermentum1 
PL32 Raw cow milk KT626416 Lactobacillus fermentum1 
PL33 Raw cow milk KT626417 Lactobacillus fermentum1 
* stocks from NPL culture collection1 isolation first reported in an earlier study [67]. 
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99% similarity to the previously published sequences 
were used as the criteria to confirm species identity. The 
sequences were aligned using the CLUSTAL W 
program of the software MEGA 7.0.2. A phylogenetic 
tree was created using forty-five 16S rDNA sequences 
comprising the thirty-two sequences of LAB used in 
this study. Thirteen sequences were obtained from 
GenBank that were firmly related to the different 
species obtained in this study. The sequence of 
Alkalibacterium olivapovliticus (AB294175) was also 
recorded and used as an outgroup. 
 
Indicator strains and culture conditions 
The pathogenic bacterial strains used in this study 
were obtained from the Health Biotechnology Division, 
National Institute for Biotechnology and Genetic 
Engineering (NIBGE), Faisalabad, Pakistan. 
Staphylococcus aureus N1, Escherichia coli SS1, and 
Salmonella enterica ser Typhi D1 were previously 
isolated from infected patients and all exhibit an MDR 
phenotype [24-26]. A non-MDR strain of Pseudomonas 
aeruginosa ATCC 9027 was chosen because it is 
regarded as a reference strain for evaluating 
antimicrobial effectiveness in standardized testing 
protocols worldwide (ATCC® MP16™). All of these 
indicator strains were cultivated for 18-24 hours in 
nutrient broth (Merck®, Darmstedt, Germany) at 37˚C 
with shaking at 200 rpm. 
 
Cell-free culture supernatant preparation 
The LAB strains were cultured in enriched media 
(MRS broth) at 37˚C for 16 hours and sub-cultured in 
fresh media of the same type until the stationary phase 
was attained (Figure 1). The cell-free supernatants 
(CFS) were obtained by centrifugation of the LAB 
cultures at 4500 ×g for 20 minutes at 4˚C and filter 
sterilized by passing through a syringe filter 
(FilterBio®, Nantong, China) of 0.22 µm pore size. 
 
Antibacterial activity of CFS by microdilution method 
Overnight cultures of pathogenic bacteria were 
inoculated into fresh liquid medium (1:100 dilution in 
nutrient broth) and grown to an OD630 of 0.1. For 
finding out the minimum percentage of CFS that 
inhibits the growth of target pathogens, the pathogenic 
cultures were incubated without CFS (control) or with 
concentrations of CFS ranging from 1 to 18% (v/v). 
Aliquots of 200 µL from each culture were immediately 
transferred to a 96-well microtiter plate (Nunc®, 
Roskilde, Denmark), which was incubated in a 
microtiter plate reader (Spectramax 384 PLUS®, 
Sunnyvale, CA, USA) at 37˚C for 16 hours. The growth 
of the pathogenic bacteria was monitored by measuring 
absorbence at 630 nm every 15 min. The antimicrobial 
activity was expressed as percent inhibition of pathogen 
growth relative to controls grown without CFS. All 
experiments were performed twice with readings taken 
in triplicate. The MIP (minimal inhibitory percentage) 
of CFS is the lowest percentage of CFS that resulted in 
≥ 95 % reduction in growth and was determined by 
subtracting the CFS/culture OD630 from that of the cell-
free medium [27]. 
 
Agar well diffusion assay 
The capacity of the shortlisted isolates to inhibit 
MDR pathogenic bacteria was also examined using 
indicator organisms in an agar well diffusion assay [28]. 
Twenty-five mL of liquefied 0.8% (w/v) nutrient agar 
was mixed with an active overnight culture of indicator 
isolate (1%, v/v), poured into sterile petri dishes and 
allowed to solidify. Wells were made with a sterile 8 
mm diameter borer and filled with CFS from the LAB 
isolates. The dishes were incubated for 2 hours at 4°C 
to permit CFS diffusion into the agar, and then all the 
plates were incubated at 37°C for 24 hours. The 
diameter (mm) of the inhibition zone was a measure of 
the extent of antimicrobial activity. The assays were 
carried out three times independently. 
 
Nature of the antibacterial metabolite 
To investigate the chemical nature of the potentially 
inhibitory substances secreted by Weissella confusa 
PL6, Enterococcus faecium PL7, Lactobacillus 
delbrueckii PL11, and PL13 strains, the CFSs were 
subjected to a variety of tests. To determine if 
Figure 1. Reduction in pH of the culture media during 24 hours 
growth of select LAB strains. 
Data are the mean ± SD of at least three independent experiments. 
(Squares indicates the growth; circles indicates pH). 
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surfactants were produced by the test strains, a drop-
collapse test was carried out as described [29]. Briefly, 
100 µL aliquots of CFS were added to wells of sterile 
96-well microtiter plates (Nunc®, Roskilde, Denmark) 
and 5 µL of crude motor oil was pipetted on top of each. 
A result was interpreted as positive for biosurfactant 
when the drop diameter was at least a millimeter larger 
than that produced by pipetting oil onto distilled water 
(negative control). Three readings were done for each 
test. To determine if organic acids were the potentially 
inhibitory substance, the CFSs were neutralized to pH 
6.5-7.0 using 2M NaOH and compared to untreated 
CFSs. To test whether the inhibitory substances were 
proteins, the CFSs wee treated with 600 mAU (Anson 
units) per mL of proteinase K (Merck, Darmstadt, 
Germany) and 250 μg/mL trypsin (Merck, Darmstadt, 
Germany). To check heat sensitivity, the CFSs were 
incubated at 80°C to 95°C for 60 minutes and 121°C for 
15 minutes. The treated CFSs (8%, v/v) and untreated 
controls were then checked for antibacterial activity as 
described above. All the experiments were performed 
in triplicate. 
Percent inhibition = (a-b)/a×100, where a = OD630 
of control (pathogen grown under optimal conditions, 
without CFS) and b = OD630 of the CFS-treated group. 
 
Organic acid identification and quantification 
To determine the stage at which the LAB strains 
produced the most acid and lowest pH, cultures were 
grown in MRS medium for 24 hours at 37°C and 2 mL 
samples were taken hourly for pH measurements of the 
supernatants . After 14 hours of growth, CFSs were 
obtained, filter-sterilized (0.22 µm, FilterBio®, 
Nantong, China) and analyzed by HPLC. The organic 
acids were identified and quantified using an Agilent 
1200 series HPLC instrument. The stationary phase was 
the Agilent Hi-Plex H column (300 × 6.5 mm), which 
was used with the Agilent PL-Hi-Plex H Column (50 × 
7.7 mm) maintained at a temperature of 65°C. Five 
millimolar sulfuric acid was used as the mobile phase 
with an isocratic flow of 0.6 mL per min. External 
standards (lactic acid, acetic acid, propionic acid, oxalic 
acid, formic acid, malic acid, and succinic acid) were 
run to identify and quantify the organic acids present in 
CFS. Both the UV spectra and retention times were 
used to confirm the identity of specific analytes. 
 
Acidic pH tolerance 
The acid tolerance assay was performed according 
to a published protocol [30] with modifications. 
Overnight-grown LAB strains were inoculated into 
sterile PBS at a pH of 3 and 7 (control) and incubated 
aerobically for 3 hours at 37°C. Following incubation, 
tenfold serial dilutions (up to 10-6) of each bacterial 
isolate were prepared using PBS, and 50 µL of 10-3 to 
10-6 dilutions were spread on MRS agar and incubated 
aerobically at 37°C for 24 h. After incubation, colonies 
on the plates were counted using a colony counter 
(QCount®, Norwood, USA) and expressed as 
CFU/mL. The tolerance to acidic conditions was 
determined by comparing the viable cell count after 
exposure to pH 3 to that at pH 7. 
 
Bile tolerance 
The capacity to withstand bile exposure was 
assessed using a published method [31] with 
modifications. LAB were harvested by centrifugation 
of 1 mL of an overnight culture at 6000 ×g for 3 
minutes. The pellets were suspended in 1 mL of fresh 
MRS broth with or without 0.3% (w/v) ox gall and 
incubated aerobically at 37°C for 3 hours. After 
incubation, tenfold serial dilutions (up to 10-6) of each 
bacterial isolate were made using PBS and 50 µL of 10-
3 to 10-6 dilution was spread on MRS agar and incubated 
aerobically at 37°C for 24 hours. Viability was assessed 
by counting the number of colonies (CFU/mL) on the 
plates. Bile tolerance was expressed as a measure of the 
difference in viable cell counts in MRS with and 
without bile. 
 
Antibiotic susceptibility testing 
Susceptibility to commonly used antibiotics is one 
of the favorable criteria for the evaluation of probiotic 
suitability. The disc diffusion test for antibiotic 
susceptibility was done with five commercially 
important antibiotics--ampicillin, erythromycin, 
kanamycin, tetracycline and streptomycin (Oxoid, 
Basingstoke, UK). The assay was based on a published 
method with slight alterations [32]. Aliquots of 100 μl 
of overnight culture were uniformly spread on brain 
heart infusion (BHI) agar (Oxoid, Basingstoke, UK) 
plates and the plates allowed to dry for half an hour. 
Discs containing each antibiotic were placed on the agar 
with sterile forceps. After 24 hours incubation in 
aerobic conditions, inhibition zones were measured and 




The strains were tested for hemolytic activity 
according to a reported procedure by incubating LAB 
on blood agar containing 5% sheep’s blood (v/v) for 48 
hours at 37°C. Strains that gave green-hued zones 
around the colonies (α-hemolysis) or showed no effect 
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on the blood plates (γ-hemolysis) were considered to be 
non-hemolytic, while strains displaying clear blood 
lysis zones around the colonies (β-hemolysis) were 
interpreted as hemolytic [33]. 
 
Test of ability to metabolize lactose 
Minimal MRS media (mMRS) agar plates were 
prepared using the standard recipe but without meat 
extract and glucose. After autoclaving, sterile filtered 
1% lactose and 50 μg/mL bromocresol purple (BCP) 
were added to the media. Overnight cultures of the 
shortlisted strains (100 μL) were spread on mMRS agar 
plates with lactose as the sole carbon source and 
incubated for 24 hours at 37°C. Lactose metabolism 
produces lactic acid which turns the BCP yellow. 
 
Statistical analysis 
The experiment were done in triplicate, and results 
are presented as the mean ± standard deviation. 
Standard deviations were determined with the 
Microsoft Excel 2019 software Microsoft Corp., 
Redmond, WA, USA). Experimental data were 
analyzed with one-way ANOVA using the SPSS 25.0 
software (IBM, Boulder, CO, USA). Statistical 
differences among means were determined by the 
Tukey HSD at the 95% confidence interval. 
 
Results 
Phylogenetic analysis of LAB strains 
To find bacterial strains to control MDR and 
pathogenic bacteria we tested thirty-two strains from 
our laboratory collecttion that were obtained previously 
from sundry local dairy sources (Table 1). The results 
of partial 16S rRNA gene sequencing showed that 
twenty-three of the strains (72%) belonged to the genus 
Lactobacillus and nine (28%) to other genera. Among 
the nine, three isolates were Ent. faecium, three were 
Weissella species, two were Streptococcus lutetiensis 
Table 2. Quantification of the antibacterial activity of LAB strains by microdilution method. 
Strain code P. aeruginosa ATCC 9027 S. aureus N1 E. coli SS1 S. enterica ser Typhi D1 
PL1 8 ± 0.54 6 ± 0.62 6 ± 0.53 6 ± 0.75 
PL3 9 ± 0.15 7 ± 0.25 7 ± 0.25 9 ± 0.56 
PL4 10 ± 0.71 6 ± 0.56 6 ± 0.95 6 ± 0.25 
PL5 8 ± 0.55 6 ± 0.25 5 ± 0.46 7 ± 0.78 
PL6 5 ± 0.23 4 ± 0.46 4 ± 0.25 5 ± 0.53 
PL7 6 ± 0.25 2 ± 0.63 3 ± 0.75 4 ± 0.25 
PL8 10 ± 0.78 7 ± 0.25 5 ± 0.56 7 ± 0.95 
PL9 8 ± 0.15 7 ± 0.25 6 ± 0.66 6 ± 0.53 
PL10 9 ± 0.56 6 ± 0.75 5 ± 0.25 6 ± 0.55 
PL11 8 ± 0.16 2 ± 0.54 4 ± 0.53 5 ± 0.71 
PL12 8 ± 0.75 6 ± 0.53 7 ± 0.73 6 ± 0.62 
PL13 5 ± 0.73 2 ± 0.65 3 ± 0.27 4 ± 0.56 
PL14 12 ± 0.28 7 ± 0.25 6 ± 0.52 6 ± 0.25 
PL15 8 ± 0.17 7 ± 0.52 6 ± 0.29 7 ± 0.64 
PL16 11 ± 0.57 8 ± 0.25 7 ± 0.78 7 ± 0.73 
PL17 12 ± 0.75 7 ± 095 7 ± 0.68 7 ± 0.25 
PL18 10 ± 0.51 7 ± 0.75 7 ± 0.25 6 ± 0.33 
PL19 12 ± 0.18 7 ± 0.46 7 ± 0.82 7 ± 0.54 
PL20 12 ± 0.25 8 ± 0.25 5 ± 0.51 7 ± 0.25 
PL21 8 ± 0.45 8 ± 0.75 6 ± 0.86 7 ± 0.62 
PL22 10 ± 0.59 8 ± 0.55 7 ± 0.25 8 ± 0.25 
PL23 8 ± 0.25 8 ± 0.25 8 ± 0.46 8 ± 0.42 
PL24 8 ± 0.82 8 ± 0.96 7 ± 0.59 8 ± 0.75 
PL25 10 ± 0.65 8 ± 0.25 7 ± 0.25 8 ± 0.64 
PL26 8 ± 0.22 8 ± 0.62 7 ± 0.75 8 ± 0.74 
PL27 8 ± 0.71 8 ± 0.75 7 ± 0.51 8 ± 0.25 
PL28 8 ± 0.52 8 ± 0.46 7 ± 0.63 7 ± 0.62 
PL29 10 ± 0.25 10 ± 0.5 6 ± 0.52 7 ± 0.15 
PL30 8 ± 0.47 8 ± 0.25 7 ± 0.75 7 ± 0.35 
PL31 10 ± 0.25 8 ± 0.78 7 ± 0.56 7 ± 0.65 
PL32 10 ± 0.56 8 ± 0.75 7 ± 0.62 6 ± 0.42 
PL33 8 ± 0.75 8 ± 0.52 7 ± 0.51 8 ± 0.52 
Values given are minimum inhibitory percentages (MIP) of CFS of LAB strains against various MDR pathogenic bacteria. Data are the mean ± SD of at least 
three independent experiments. 
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and one was Leuconostoc lactis. The species 
verification was further strengthened by phylogenetic 
analysis in which the strains clustered in the identified 
species clades, including twelve species sequences of 
the NCBI GenBank (Supplementary Figure 1). All the 
sequences were already deposited in NCBI-GenBank 
along with location and source of the strains. 
 
Antibacterial activity of LAB isolates 
Cell-free supernatant (CFS) from the LAB isolates 
were tested against the indicator strains using the broth 
microdilution method and all significantly inhibited 
pathogen growth. Only four LAB isolates (W. confusa 
PL6, Ent. faecium PL7, and L. delbrueckii PL11 and 
PL13) showed maximum inhibition below 6 % of CFS 
for all tested pathogens (Table 2).  
 
Acid tolerance 
Tolerance to acid is one of the prerequisites for an 
effective probiotic. The LAB isolates, W. confusa PL6, 
Ent. faecium PL7, L. delbrueckii PL11 and PL13, were 
chosen for acid tolerance analysis because they had the 
greatest antimicrobial activity. The strains PL7, PL11 
and PL13 showed good tolerance to pH 3 during the 3 
hours incubation (Table 3), although the colony count 
was significantly decreased compared to controls at pH 
7. The viability of the isolates decreased with 
decreasing pH and increasing incubation time. The W. 
confusa isolate PL6 showed the largest decrease in 
CFU/mL from 3.9×1010 to 1.5×108 at pH 3 for 3 hours 
of incubation, whereas PL7, PL11 and PL13 showed 
less reduction in the viable cell numbers. 
Bile Tolerance 
The sensitivity of lactobacilli to oxbile did not 
exhibit significant variance among the test strains, since 
all of them tolerated 0.3% oxbile. Out of the four 
shortlisted strains, PL7 demonstrated the most tolerance 
albeit slightly as it maintained a log 6 count of viable 
cells post-exposure to bile for 3 hours (Table 3). 
 
Antibiotic susceptibility 
The antibiotic resistance of W. confusa PL6, Ent. 
faecium PL7, and L. delbrueckii PL11 and PL13 was 
analyzed (Table 4). All isolates were susceptible to all 
tested antibiotics; therefore, there is no risk of 
transmission of antibiotic resistance from the isolates to 
pathogenic bacteria. 
 
Antibacterial activity of CFSs subjected to heat, acid 
neutralization and protease digestion 
The spectrum of antibacterial activity of select LAB 
strains was broad as they inhibited the growth of both 
gram positive and gram negative pathogenic bacterial 
strains on solid media (Supplementary Table 1). To 
determine the nature of the inhibitory substances 
secreted by the four best LAB strains, their CFSs were 
treated in various ways and then tested for antibacterial 
activity against pathogens. Proteinase K, trypsin and 
heat treatment had no impact on the inhibitory effect 
(data not shown). In order to quantifiy and assess the 
magnitude of the antibacterial activity of elaborated 
organic acids and metabolities, Cell-free supernatant 
(CFS) from the LAB isolates were tested against the 
indicator strains using the broth microdilution method 
Table 3. Survival of W. confusa PL6, Ent. faecium PL7, L. delbrueckii PL11 and PL13 strains in the presence of low pH and bile. Means within 
a row are not statistically significant (p > 0.05). 
LAB 
Strains 
pH assay Bile assay 
Cell viability (log CFU/mL) Reduction in cell 
viability (log units) 
Cell viability (log CFU/mL) Reduction in cell 
viability (log units) pH 7 pH 3 Bile 0% Bile 0.3% 
PL-6 10.59±0.15 8.18±0.17 2.41 9.10±0.12 8.59±0.16 0.51 
PL-7 8.94±0.13 7.03±0.15 1.91 7.60±0.18 6.08±0.19 1.52 
PL-11 8.66±0.09 8.55±0.12 0.11 8.03±0.17 6.79±0.15 1.24 
PL-13 7.79±0.25 6.81±0.22 0.98 7.34±0.15 5.79±0.12 1.55 
 
Table 4. Antibiotic susceptibility of W. confusa PL6, Ent. faecium PL7, L. delbrueckii PL11 and PL13 analyzed using the agar disc diffusion 













PL-6 14±0.12S 27±0.32 S 20±0.21 S 25±0.23 S 37±0.42 S 
PL-7 15±0.24 S 27±0.29 S 22±0.23 S 22±0.32 S 35±0.28 S 
PL-11 17±0.19 S 25±0.22 S 20±0.18 S 28±0.26 S 32±0.32 S 
PL-13 16±0.09 S 25±0.26 S 19±0.19 S 25±0.07 S 29±0.38 S 
S susceptible. 
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and all significantly inhibited pathogen growth (Figure 
2). The CFS of four LAB isolates (W. confusa PL6, Ent. 
faecium PL7, and L. delbrueckii PL11 and PL13) out of 
the tested panel was found to be most inhibitory (MIP 
< 6 % v/v of CFS) for all tested pathogens (Table 2). 
 
pH decrease with grooth of LAB strains 
The four LAB isolates were grown on MRS media 
and decrease in pH was monitored. The pH of the 
growth media dropped from pH 6.2 to 4.3 following 24 
hours incubation, and no statistical difference was 
observed between the different LAB strains tested 
(Figure 1). The pH decreased until the stationary phase 
has been achieved, and after that, it remains more or less 
constant. The CFS of cultures incubated for 14 hours 
were used for HPLC analysis. 
 
Organic acids 
The organic acid profiles of W. confusa PL6, Ent. 
faecium PL7, L. delbrueckii PL11 and PL13 are 
presented in (Figure 3). Lactic acid was the most 
abundant organic acids produced followed by acetic 
acid and propionic acid, respectively. The amount of 
lactic acid production varied among the strains ranging 
from 1.65 to 2.77 g/L. The highest concentration of 
lactic acid (2.77 g/L) was produced by Ent. faecium PL7 
(Table 5). The acetic acid concentration also varied and 
was most abundantly produced by L. delbrueckii PL13. 
Production of propionic acid was similar in all four 
tested strains. Other acids such as oxalic, formic, malic 
and succinic were produced in trace amounts or not 
produced by the strains. 
 
Discussion 
This study aimed to screen LAB isolated from 
indigenous dairy sources for those possessing 
antibacterial activity against MDR and pathogenic 
bacteria. Fermented dairy products produced locally are 
of microbiological interest since products such as dahi 
(yogurt) constitute an integral part of the South Asian 
diet and are made by the traditional back-slopping 
method without the use of commercial starters. This 
approach practiced over centuries has resulted in the 
creation of a rich blend of mixed cultures containing 
indigenous species and strain variations differing from 
region to region [34]. Artisanal dairy products are 
known to harbor diverse probiotics LAB [35]. 
Exploring the antagonistic potential of LAB species 
from indigenous South Asian fermented produce 
against human pathogens is not without precedent, as 
many studies suggest [36]; however, their postbiotic 
characteristics have been little explored even though 
some have found application in animal feed and cancer 
therapy [37]. Species identification was made through 
the widely established 16S rRNA gene sequencing 
Figure 2. Antagonism of pathogenic bacteria following their 
exposure to CFS (untreated) and neutralized (Neutral) of select 
LAB strains. Data are the mean ± SD of at least three independent 
experiments. 
Table 5. Organic acid quantification by HPLC. 
LAB Strains Lactic acid (g/L) Acetic acid (g/L) Propionic acid (g/L) 
Enterococcus faecium PL7 2.776 ± 0.02 0.906 ± 0.02 0.599 ± 0.01 
Lactobacillus delbrueckii PL11 1.621 ± 0.06 0.979 ± 0.02 0.525 ± 0.01 
Lactobacillus delbrueckii PL13 1.653 ± 0.05 0.983 ± 0.01 0.534 ± 0.01 
Weissella confusa PL6 2.587 ± 0.03 0.742 ± 0.01 0.579 ± 0.01 
 
Figure 3. Chromatogram: A Standard organic acids solution, B 
CFS of the LAB strains. 
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technique [38] which revealed all as LAB species. A 
prevalence of Lactobacillales especially lactobacilli in 
artisanal dairy fermentations is known [39]. Naturally 
fermented products of tropical origin have a 
predominance of mesophilic lactobacillus species such 
as L. fermentum [40] whereas L. delbrueckii is a 
thermophilic starter species, typically found in cheese 
and fermented milk products [41]. A multitude of 
antimicrobial substances is known to be elaborated by 
LAB and many have been identified and characterized 
for their antimicrobial activity. They range from 
organic acids derived from primary bacterial 
metabolism to complex macromolecules arising from 
bioconversion or protein synthesis [42]. Analysis of 
CFS represents a reliable way of assessing early on, the 
potential of candidate probiotics [43]. The 
characterization of the CFS of these strains which 
showed an effect of pH neutralization but not of 
proteolytic enzymes (data not shown), and an absence 
of biosurfactants, suggests that the metabolic acids are 
the underlying cause of antimicrobial action. Although 
CFSs of bacterial cultures contain many different 
metabolites, the bulk of evidence points to organic acids 
as the principal antibacterial agents [44,45]. 
Homofermenters such as enterococci can produce large 
amounts of lactic acid as shown here; consequently, 
some Ent. faecium strains are being used for its 
industrial production [46]. The L. delbrueckii, strains 
PL11 and PL13, are also obligate homofermenters, 
producing abundant lactic acid. High lactate production 
is a hallmark of this species. Of the two species most 
frequently used as starters in commercial yogurt 
making, L. delbrueckii produces greater amounts of 
lactate than S. thermophilus [47]. Production of both 
lactic and acetic acids as seen here, can act 
synergistically to produce low pH [48]. Similar 
amounts of propionic acid were produced by all four 
tested strains but at much lower levels than lactic and 
acetic acids. Propionic acid is not considered a major 
organic acid of LAB species and consequently does not 
contribute much to the antibacterial activity against 
food pathogens compared to lactic and acetic acids [1]. 
The three organic acids elaborated by these strains are 
volatile short-chain fatty acids (VSFAs) [49], and of the 
three, lactic acid (pKa of 3.08) has the weakest 
antagonistic potential [50]. Lactic acid has a broad 
spectrum of activity, acting on both Gram-positive and 
-negative bacteria, as evident in our findings as well as 
the literature; but, it has been suggested that its 
inhibitory action is more pronounced on Gram-negative 
cells owing to cell wall differences [51,52], which was 
not supported by our findings. This variance in 
antimicrobial activity observed in this study might be 
due to subtle differences in the CFS composition of 
these different species, as organic acids have been 
reported to activate metabolites by acidification or 
mediate their insertion into membranes [53]. Even 
though, the alkaline environment of the colon should 
neutralize the organic acids generated by the resident 
LAB cells, a localized pH gradient is widely accepted 
as a plausible mechanism for pathogen elimination [53].  
Acid and bile resistance are prerequisites for 
probiotic function because ingested strains need to 
survive the harsh environment of the GIT. These 
characteristics are often assessed in vitro in the 
preliminary selection of a probiotic strain. The human 
stomach typically secretes about 2.5 L of gastric juice 
daily which has a pH varying from a low of 1.5 (fasting) 
to 3.5, after a meal has been eaten [54]. About 1 L of 
bile synthesized in the liver is secreted into the small 
intestine daily, which an ingested potential probiotic 
also needs to survive [55]. The ability of these LABs to 
tolerate bile salts at a concentration of 0.3% is 
physiologically significant as being similar to the bile 
concentration in the human intestine [56]. Losing up to 
a third of cells as seen here for the W. confusa strain 
following exposure to physiological levels of acid and 
bile should not be considered as grounds for precluding 
it as a potential probiotic [57]. The tolerance of bacteria 
to such a harsh environment produced by acid and bile 
is attributed to the production of ATPases, bile salt 
hydrolases and other enzymes [58] and our results 
suggest that these strains are likely to persist in the 
human GIT. 
Although, LABs are extensively used in the 
production of fermented food products and food 
preservation, these microorganisms have the potential 
ability to transfer antibiotic resistance to pathogenic 
species. Therefore, evaluation of antibiotic 
susceptibility is strongly advised for all bacteria with 
application in the food industry, especially those which 
are to be used as probiotics [59]. Disc diffusion assay is 
a CLSI recognized way of evaluating antimicrobial 
sensitivities [60]. A susceptibility towards most of the 
commonly used antibiotics, therefore, obviates 
concerns of antibiotic resistance transmission from 
putative probiotics to other pathogens or gut 
commensals. Hemolytic activity is a trait associated 
with virulence in some food-associated 
microorganisms. Our results concur with past findings 
where LAB strains of dairy origin were reported to have 
no hemolytic activity [61]. 
A functionally active bacterial β-D-galactosidase 
found in many LAB is involved in lactose breakdown. 
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There is evidence of probiotics having an ameliorative 
effect on lactose intolerance [18]. Exogenous intake of 
lactases of microbial origin has shown promise as a 
treatment option for lactose intolerance [62]. 
 
Conclusions 
W. confusa PL6, Ent. faecium PL7, and L. 
delbrueckii PL11 and PL13 were all capable of 
fermenting lactose and producing lactic acids that 
inhibited MDR human pathogens in vitro. The variation 
in the quantities of organic acids produced in our LAB 
strains is in line with previous contentions where type 
and quantities of post-biotics of lactobacilli vary from 
strain to strain [21]. Post-biotics are purported to not 
only enhance the potency of probiotics but also present 
a more effective and safer way of delivering desired 
health effects without the technical challenges 
associated with probiotics. Their value in food 
manufacturing and preservation cannot be 
overemphasized especially in the context of developing 
countries [63]. The quantities of lactic acid produced by 
the L. delbrueckii species in our study are similar to 
what has been reported elsewhere [64]. In contrast, the 
high levels of lactic acid observed in the W. confusa 
strain, a typically facultative heterofermenting species 
which matched and even surpassed that of some the 
homofermentative lactobacillus strains in our work 
suggests its post-biotic value. However, unlike Ent. 
faecium which because of its distinct probiotic 
applications is a good candidate for qualified 
presumption of safety (QPS) status [65], the 
investigations of W. confusa carried out so far, suggest 
that its potential as a probiotic and as a post-biotic must 
be empirically demonstrated at the strain level [66] 
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Annex – Supplementary Items 
 
Supplementary Table 1. Antibacterial activity of the shortlisted LAB strains by agar well diffusion assay (mean ± SD of diameter of inhibition 
zones in mm). 
Indicator strains PL6 PL7 PL11 PL13 
E. coli SS1 17.27 ± 0.39 18.37 ± 0.28 19.92 ± 0.31 18.43 ± 0.34 
P. aeruginosa ATCC 
9027 18.26 ± 0.38 19.96 ± 0.35 17.23 ± 0.23 19.73 ± 0.32 
S. enterica ser Typhi D1 19.25 ± 0.50 20.37 ± 0.49 21.13 ± 0.38 20.62 ± 0.25 
S. aureus N1 19.25 ± 0.44 19.87 ± 0.55 19.75 ± 0.45 19.75 ± 0.28 
 
 
Supplementary Figure 1. Phylogenetic analysis of LAB isolates. 
This was inferred using the neighbor-joining method by MEGA7. NCBI Accession numbers are also given with the LAB strains. 
